KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Change in Account Payables (2016 - 2020)

Supernus Pharmaceuticals has reported Change in Account Payables over the past 7 years, most recently at $5.7 million for Q3 2020.

  • Quarterly Change in Account Payables rose 564.92% to $5.7 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $5.8 million through Sep 2020, up 182.67% year-over-year, with the annual reading at $7.0 million for FY2019, 294.58% up from the prior year.
  • Change in Account Payables was $5.7 million for Q3 2020 at Supernus Pharmaceuticals, up from -$182000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $7.3 million in Q4 2019 and troughed at -$7.0 million in Q1 2020.
  • The 5-year median for Change in Account Payables is -$380000.0 (2016), against an average of $247736.8.
  • Year-over-year, Change in Account Payables soared 937.63% in 2017 and then crashed 1060.12% in 2018.
  • A 5-year view of Change in Account Payables shows it stood at $5.1 million in 2016, then tumbled by 86.43% to $692000.0 in 2017, then crashed by 1060.12% to -$6.6 million in 2018, then surged by 209.81% to $7.3 million in 2019, then fell by 22.26% to $5.7 million in 2020.
  • Per Business Quant, the three most recent readings for SUPN's Change in Account Payables are $5.7 million (Q3 2020), -$182000.0 (Q2 2020), and -$7.0 million (Q1 2020).